HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia.

Abstract
Heparin-induced thrombocytopenia (HIT) is caused by antibodies against a "self" protein-platelet factor 4-bound to heparin. We observed an overrepresentation of the female gender in 290 patients who developed HIT after cardiac or orthopedic surgery compared with the representation found in national databases (study 1). Therefore, we investigated gender imbalance in HIT by logistic regression analysis of a randomized controlled trial of unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) (study 2), and we analyzed individual patient data from 7 prospective studies comparing HIT frequency between UFH and LMWH, evaluating effects of gender, heparin (UFH vs LMWH), and patient type (surgical vs medical) (study 3). All 3 studies showed female overrepresentation, which for study 3 was a common odds ratio (OR) of 2.37 (95% confidence interval [95% CI], 1.37-4.09; P = .0015). Study 3 also showed an interaction between gender, heparin, and patient type. Although UFH was more likely than LMWH to cause HIT (P < .0001), this effect was predominantly seen in women compared with men (common OR, 9.22 vs 1.83; P = .020) and in surgical patients compared with medical patients (common OR, 13.93 vs 1.75; P = .005). We conclude that females are at greater risk for HIT and that using LMWH to prevent HIT may have greatest absolute benefit in females undergoing surgical thromboprophylaxis.
AuthorsTheodore E Warkentin, Jo-Ann I Sheppard, Christopher S Sigouin, Thomas Kohlmann, Petra Eichler, Andreas Greinacher
JournalBlood (Blood) Vol. 108 Issue 9 Pg. 2937-41 (Nov 01 2006) ISSN: 0006-4971 [Print] United States
PMID16857993 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Heparin
Topics
  • Databases, Factual
  • Female
  • Heparin (adverse effects)
  • Humans
  • Male
  • Randomized Controlled Trials as Topic
  • Regression Analysis
  • Risk Factors
  • Sex Characteristics
  • Surgical Procedures, Operative
  • Thrombocytopenia (chemically induced, epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: